Monitoring UNCY open interest helps you see where real money is positioned on Unicycive Therapeutics Inc's options and which strikes are attracting the most commitment from traders. Unicycive Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor UNCY options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising UNCY options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Unicycive Therapeutics Inc to settle.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where UNCY open interest is concentrated. Our scanner maps Unicycive Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Unicycive Therapeutics Inc's options open interest as the signal it is, not as an afterthought.
